The role of immune and inflammatory cells in idiopathic pulmonary fibrosis
The contribution of the immune system to idiopathic pulmonary fibrosis (IPF) remains poorly
understood. While most sources agree that IPF does not result from a primary …
understood. While most sources agree that IPF does not result from a primary …
Emerging targets of disease-modifying therapy for systemic sclerosis
ER Volkmann, J Varga - Nature Reviews Rheumatology, 2019 - nature.com
Systemic sclerosis (SSc) has the highest cause-specific mortality of all the connective tissue
diseases, and the aetiology of this complex and heterogeneous condition remains an …
diseases, and the aetiology of this complex and heterogeneous condition remains an …
Extracellular mitochondrial DNA is generated by fibroblasts and predicts death in idiopathic pulmonary fibrosis
Rationale: Idiopathic pulmonary fibrosis (IPF) involves the accumulation of α-smooth muscle
actin–expressing myofibroblasts arising from interactions with soluble mediators such as …
actin–expressing myofibroblasts arising from interactions with soluble mediators such as …
Biomarkers in idiopathic pulmonary fibrosis
F Drakopanagiotakis, L Wujak, M Wygrecka, P Markart - Matrix Biology, 2018 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic, debilitating, fibrotic lung disease leading to
respiratory failure and ultimately to death. Being the prototype of interstitial lung diseases …
respiratory failure and ultimately to death. Being the prototype of interstitial lung diseases …
PINK1 attenuates mtDNA release in alveolar epithelial cells and TLR9 mediated profibrotic responses
M Bueno, D Zank, I Buendia-Roldán, K Fiedler… - PLoS …, 2019 - journals.plos.org
We have previously shown that endoplasmic reticulum stress (ER stress) represses the
PTEN inducible kinase 1 (PINK1) in lung type II alveolar epithelial cells (AECII) reducing …
PTEN inducible kinase 1 (PINK1) in lung type II alveolar epithelial cells (AECII) reducing …
[HTML][HTML] Molecular and genetic biomarkers in idiopathic pulmonary fibrosis: where are we now?
I Tomos, I Roussis, AM Matthaiou, K Dimakou - Biomedicines, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) represents a chronic progressive fibrotic interstitial lung
disease of unknown cause with an ominous prognosis. It remains an unprecedent clinical …
disease of unknown cause with an ominous prognosis. It remains an unprecedent clinical …
Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis
RC Russo, VFJ Quesniaux, B Ryffel - Trends in Immunology, 2023 - cell.com
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic interstitial lung disease (ILD) that affects
lung mechanical functions and gas exchange. IPF is caused by increased fibroblast activity …
lung mechanical functions and gas exchange. IPF is caused by increased fibroblast activity …
The role of mitochondrial DNA in mediating alveolar epithelial cell apoptosis and pulmonary fibrosis
Convincing evidence has emerged demonstrating that impairment of mitochondrial function
is critically important in regulating alveolar epithelial cell (AEC) programmed cell death …
is critically important in regulating alveolar epithelial cell (AEC) programmed cell death …
Neutrophil extracellular traps activate lung fibroblast to induce polymyositis‐related interstitial lung diseases via TLR9‐miR‐7‐Smad2 pathway
S Zhang, X Jia, Q Zhang, L Zhang… - Journal of Cellular …, 2020 - Wiley Online Library
Excessive neutrophil extracellular trap (NET) formation may contribute to polymyositis (PM)‐
associated interstitial lung diseases (ILD), but the underlying mechanism is not fully …
associated interstitial lung diseases (ILD), but the underlying mechanism is not fully …
Heterogeneity of fibroblasts and myofibroblasts in pulmonary fibrosis
Abstract Purpose of Review Idiopathic pulmonary fibrosis (IPF) is the most common form of
interstitial lung disease of unknown etiopathogenesis with mean survival of 3–5 years and …
interstitial lung disease of unknown etiopathogenesis with mean survival of 3–5 years and …